Financing, Equity Capital Markets

Nuvalent, Inc.

10/23
|
$300.0 Million
Navalent
Piper Sandler served as bookrunner for Nuvalent, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma